A simple and inexpensive new test can diagnose patients with antibiotic-resistant strains of bacteria in a matter of minutes.

Women who are overweight or obese have up to twice the risk of developing colorectal cancer before age 50 as women who have what is considered a normal body mass index (BMI), according to new research led by Washington University School of Medicine in St. Louis.

This study of "bacterial linguistics," attempts to identify the "words" that bacteria use to communicate.

When you go to the shops to buy the weekly groceries, it’s quite likely you’ll find yourself thinking about where your food has come from. Is this organic? Is that free-range? You are perhaps less likely to find yourself wondering, “Is this food fake?”

The world of microfluidics has generated a host of intricate tools on a microscale, ranging from cheap paper-based lateral flow tests to organ-on-a-chip models designed to facilitate personalized diagnostic tests.
This article explores the extent to which microfluidic tools are filling a gap in clinical and point-of-care diagnostics, and touches on how microfluidics could improve the drug discovery process.

Integrating new technologies into laboratory workflows can be a complex transition. This article outlines why, when it comes to diagnosing infections, it's an investment worth making.

Artificial intelligence (AI) has begun to transform the world of healthcare and researchers across the globe are now dedicated to discovering its potential. This technology has particularly struck a chord with cancer research surrounding early detection, a long-standing concern for the cancer community.

A growing number of life science businesses are turning to greater supply chain collaboration for benefits like accelerated time to market, improved quality, reduced risk and more rapid and widespread innovation. But while 68% of executives in this industry say active and meaningful engagement with suppliers is essential to success, far too many, over a third, struggle to implement it.

This article explores the current state of play within the area of cancer proteomics, highlights some of the techniques used to investigate the proteome, and looks at the impact of combining proteomics with other ‘omics’ in relation to cancer research.